PPARA and neoplasm: Interestingly, many in vitro and in vivo studies reported the successful use of PPAR agonists, and in particular of TZDs, in the inhibition of NB cell proliferation and tumor growth, in the induction of cell death, and in the promotion of cell differentiation.